SUBSCRIBE
SUBSCRIBE
News   FDA

U.S. Clears GlaxoSmithKline Drug For Preventing Influenza

March 29, 2006 | 
1 min read
WASHINGTON (Reuters) - GlaxoSmithKline Plc's prescription flu treatment Relenza has won U.S. approval for preventing influenza in adults and children ages 5 and older, regulators said on Wednesday.

FDA Approvals
GlaxoSmithKline
MORE ON THIS TOPIC
Brain neuro cell growth or damaging drawing with texture shading illustration isolated on dark background
Approvals
Biogen, Eisai Win FDA Nod for Subcutaneous Maintenance Leqembi
September 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Whitchurch-Stouffville, On, Canada: - May 30, 2021: Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada. Teva Pharmaceutical Industries Ltd. is an Israeli pharmaceutical company.
Obesity
Teva Brings First GLP-1 Generic for Obesity, Targets Novo’s Saxenda
August 29, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccine and syringe injection. Doctor hand with syringe. Vaccination of people for prevention, immunization and treatment from virus infection. Medicine, flu shot, test with needle. Vector
Vaccines
FDA Clears Updated COVID-19 Shots From Pfizer, Moderna, Novavax—But With Restrictions
August 28, 2025
 · 
2 min read
 · 
Tristan Manalac
A pit crew working on a race car
Regulatory
The US Is Losing Its Biopharma Edge, Writes Former FDA Commissioner
August 27, 2025
 · 
3 min read
 · 
Dan Samorodnitsky